Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
ST. LOUIS - Reinsurance Group of America, Incorporated (NYSE:RGA), a $13 billion market cap insurance giant with an "GREAT" InvestingPro Financial Health score, announced Wednesday it has made a strategic investment in FoxPath Capital Partners, a New York-based credit secondaries investment firm.
The transaction includes a multi-fund anchor commitment to FoxPath, which specializes in private credit secondary markets. Financial terms were not disclosed.
RGA, which reported approximately $4.1 trillion of life reinsurance in force and total assets of $133.5 billion as of June 30, 2025, said the investment will expand its access to private assets in the growing credit secondary market.
"Our investment in FoxPath reflects RGA’s ongoing dedication to innovative partnerships that strengthen our investment portfolio," said Leslie Barbi, Executive Vice President and Chief Investment Officer at RGA.
FoxPath Capital Partners, founded in 2023, focuses on providing liquidity solutions in private credit markets. The firm is led by Managing Partner Tony Colarusso and Chief Investment Officer Brian Laureano.
"This collaboration with RGA not only accelerates our growth trajectory but also enhances our capacity to deliver innovative capital solutions to the private credit markets," said Laureano.
Goodwin Procter LLP served as legal advisor to RGA in the transaction, while Piper Sandler & Co. acted as financial advisor and Akin Gump as legal advisor to FoxPath, according to the press release statement.
In other recent news, Reinsurance Group of America (RGA) reported its second-quarter 2025 earnings, which fell short of market expectations. The company announced earnings per share (EPS) of $4.72, missing the anticipated figure of $5.56, resulting in a negative surprise of 15.11%. Revenue for the quarter was reported at $5.6 billion, slightly below the forecasted $5.67 billion, leading to a revenue surprise of -1.23%. These results mark a significant miss for the company, reflecting challenges in meeting analyst projections. Following the earnings announcement, analysts may reassess their outlook on RGA, considering the missed targets. Investors often closely watch such earnings reports to gauge a company’s financial health and future potential. The earnings miss highlights the importance of accurate forecasting and the impact of market expectations on investor sentiment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.